Biome Australia Limited (ASX:BIO) Reports Strong Q3 FY25 Sales Growth
Biome Australia (ASX:BIO) reports a 41% increase in Q3 FY25 sales revenue, highlighting strong growth and positive future outlook.
Category: Companies
Vulcan Energy (ASX:VUL) Announces Financing Update and German RMF Progress
Vulcan Energy (ASX:VUL) updates Phase One Project financing with potential German Raw Materials Fund participation and adjusts project timelines.
Southern Cross Electrical Engineering Limited (ASX:SXE) Completes Acquisition of Force Fire Holdings
Southern Cross Electrical Engineering Limited (ASX:SXE) completes the acquisition of Force Fire Holdings, enhancing its fire safety solutions and strategic capabilities.
HMC Capital Limited (ASX:HMC) Declares $300M Interim FY25 Distribution and Launches Fund II
HMC Capital (ASX:HMC) declares a $300M interim FY25 distribution and launches HMCCP Fund II, enhancing its financial position.
BPH Global Ltd (ASX:BP8) Reports Encouraging Phase 2 Assay Results
BPH Global Ltd (ASX:BP8) reports significant increases in gold and silver concentrations from Phase 2 seaweed cultivation, marking a key R&D milestone.
Vanguard Investments Australia Ltd (ASX:VIF) Announces Final ETF Distribution
Vanguard Investments Australia Ltd (ASX:VIF) announces final distribution amounts and timetable for its ETFs.
Euro Manganese Inc. (ASX:EMN) Announces 5-for-1 Share Consolidation
Euro Manganese Inc. (ASX:EMN) announces a 5-for-1 share consolidation effective March 31, 2025, impacting its trading on TSXV and ASX.
Vanguard Investments Australia Ltd (ASX:VCF) Announces Final ETF Distributions
Vanguard Investments Australia Ltd (ASX:VCF) announces final distribution amounts and timetable for its ETFs, effective April 2025.
African Gold Limited (ASX:A1G) Announces Strong Drilling Results at Didievi Project
African Gold (ASX:A1G) reports remarkable drilling results at the Didievi project, emphasizing resource growth and a strategic partnership with Montage Gold.
Mesoblast (ASX:MSB) Secures Medicaid Agreement for Ryoncil®
Mesoblast (ASX:MSB) enters Medicaid agreement with CMS for Ryoncil®, enabling treatment for children with SR-aGvHD.